Literature DB >> 2981302

Differential renal function in unilateral renal injury: possible effects of radiopharmaceutical choice.

A Taylor, R Lallone.   

Abstract

An abnormal filtration fraction or a significant divergence between a kidney's ability to extract Tc-99m dimercaptosuccinic acid (DMSA) and other function parameters, such as the glomerular filtration rate (GFR) or the effective renal plasma flow (ERPF), could lead to different estimates of relative or absolute renal function, depending on the radiopharmaceutical administered. To evaluate this possible divergence, we measured the relative GFR (I-125 iothalamate), ERPF (I-131 hippurate), and Tc-99m DMSA accumulation in adult male Sprague-Dawley rats with unilateral ureteral obstruction or unilateral ischemia at various times after renal injury. The relative ERPF of the obstructed kidney was significantly greater than the relative GFR at all time periods studied; significant but less dramatic differences were noted comparing DMSA with GFR in obstruction and DMSA and ERPF with GFR in ischemia. In evaluating renal disease, it is important to consider the functional parameter reflected by the administered radiopharmaceutical as well as the underlying disease state.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981302

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  10 in total

1.  SNMMI Procedure Standard/EANM Practice Guideline for Diuretic Renal Scintigraphy in Adults With Suspected Upper Urinary Tract Obstruction 1.0.

Authors:  Andrew T Taylor; David C Brandon; Diego de Palma; M Donald Blaufox; Emmanuel Durand; Belkis Erbas; Sandra F Grant; Andrew J W Hilson; Anni Morsing
Journal:  Semin Nucl Med       Date:  2018-03-16       Impact factor: 4.446

2.  Renal uptake of dimercaptosuccinic acid and glomerular filtration rate in chronic nephropathy at angiotensin converting enzyme inhibition.

Authors:  A L Kamper; H S Thomsen; S L Nielsen; S Strandgaard
Journal:  Eur J Nucl Med       Date:  1990

3.  Evaluation of Renal Function in Obstructed Ureter Model Using 99mTc-DMSA.

Authors:  Seok Jin Jang; Byung Soo Choi; Seok Hwa Choi
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

Review 4.  Radionuclides in nephrourology, Part 2: pitfalls and diagnostic applications.

Authors:  Andrew T Taylor
Journal:  J Nucl Med       Date:  2014-03-03       Impact factor: 10.057

5.  Two routes for 99mTc-DMSA uptake into the renal cortical tubular cell.

Authors:  A M Peters; D H Jones; K Evans; I Gordon
Journal:  Eur J Nucl Med       Date:  1988

6.  The effect of radiopharmaceutical choice on the assessment of the relative renal function in upper urinary tract obstruction.

Authors:  V Sedlak-Vadoc; M Basić; S Kaludjerski; G Marusić; M Negrojević; R Borota
Journal:  Eur J Nucl Med       Date:  1988

7.  Evaluation of (123)I-orthoiodohippurate single kidney clearance rate by renal sequential scintigraphy in a large cohort of likely normal subjects aged between 0 and 18 years.

Authors:  Alessio Imperiale; Catia Olianti; Giannetto Comis; Giuseppe La Cava
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-28       Impact factor: 10.057

8.  Comparison of the Relative Renal Function Calculated with 99mTc-Diethylenetriaminepentaacetic Acid and 99mTc-Dimercaptosuccinic Acid in Children.

Authors:  Tanju Çelik; Hülya Yalçin; Emel Ceylan Günay; Aynur Özen; Cahit Özer
Journal:  World J Nucl Med       Date:  2014-09

9.  Can Tc 99m DTPA be Used in Adult Patients in Evaluation of Relative Renal Function Measurement as the Reference Tc 99m DMSA Method?

Authors:  Hülya Yalçın; Aynur Ozen; Emel Ceylan Günay; Inci Aliç Ozaslan; Cahit Ozer
Journal:  Mol Imaging Radionucl Ther       Date:  2011-04-01

10.  Acute urinary obstruction during 99mTc-ethylenedicysteine diuretic renal scintigraphy acquisition: Is furosemide the culprit?

Authors:  Shelvin Kumar Vadi; Anish Bhattacharya; Ashwani Sood; Bhagwant Rai Mittal
Journal:  World J Nucl Med       Date:  2020-01-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.